DermTech International's Series B Round

DermTech International raised a round of funding on August 20, 2013.

DermTech develops and commercializes qPCR assays for skin samples collected non-invasively using adhesive tape biopsy methods. The Company's assays can analyze multiple gene targets to assess their le…

Articles about DermTech International's Series B Round: